112 related articles for article (PubMed ID: 30115676)
1. MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.
Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1643-1649. PubMed ID: 30115676
[TBL] [Abstract][Full Text] [Related]
2. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
Cianfoni A; Niku S; Imbesi SG
AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology.
Saridas F; Mesut G; Ceylan CY; Ozpar R; Ozsen M; Koc ER; Tolunay S; Hakyemez B; Turan OF
Mult Scler Relat Disord; 2024 May; 85():105537. PubMed ID: 38460252
[TBL] [Abstract][Full Text] [Related]
4. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
Ongphichetmetha T; Aungsumart S; Siritho S; Apiwattanakul M; Tanboon J; Rattanathamsakul N; Prayoonwiwat N; Jitprapaikulsan J
Sci Rep; 2024 Jan; 14(1):1426. PubMed ID: 38228919
[TBL] [Abstract][Full Text] [Related]
5. Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms.
Lin X; Yu WY; Liauw L; Chander RJ; Soon WE; Lee HY; Tan K
Neurol Clin Pract; 2017 Feb; 7(1):53-64. PubMed ID: 29849229
[TBL] [Abstract][Full Text] [Related]
6. A Rare and Challenging Presentation of Acute Hemorrhagic Leukoencephalitis With Tumefactive Demyelinating Lesions in a 41-Year-Old Male.
Iltaf Mairajuddin S; Salim Inshasi JS; Channa RMA; Anwar Siddiqi S; Shaffi Al Madani AAR; Flayyih R
Cureus; 2024 Apr; 16(4):e58282. PubMed ID: 38752096
[TBL] [Abstract][Full Text] [Related]
7. Tumor-like Lesions in Primary Angiitis of the Central Nervous System: The Role of Magnetic Resonance Imaging in Differential Diagnosis.
Zedde M; Napoli M; Moratti C; Pavone C; Bonacini L; Di Cecco G; D'Aniello S; Grisendi I; Assenza F; Boulouis G; Nguyen TN; Valzania F; Pascarella R
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535038
[TBL] [Abstract][Full Text] [Related]
8. Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis.
Azzimonti M; Margoni M; Zanetta C; Genovese F; Martinelli V; Rocca MA; Baldoli C; Moiola L; Filippi M
J Neurol; 2024 Apr; 271(4):1663-1667. PubMed ID: 38153549
[No Abstract] [Full Text] [Related]
9. Tumor or Demyelination? Three Tumefactive Multiple Sclerosis Case Reports and Literature Review.
Qi F; Zhang Y; Li X; Fan J; Tan H; Quan C
World Neurosurg; 2024 Apr; 187():141-146. PubMed ID: 38641243
[TBL] [Abstract][Full Text] [Related]
10. Tumefactive perivascular space of the anterior temporal lobe.
Agarwal A; Vibhute P
J Neurosci Rural Pract; 2024; 15(1):150-152. PubMed ID: 38476437
[No Abstract] [Full Text] [Related]
11. Demyelinating and Neuroinflammatory Diseases of the Brain and the Spine.
Forghani R; Srinivasan A
Magn Reson Imaging Clin N Am; 2024 May; 32(2):xv-xvi. PubMed ID: 38555149
[No Abstract] [Full Text] [Related]
12. Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome.
Hardy TA
Curr Opin Neurol; 2019 Jun; 32(3):467-474. PubMed ID: 30844860
[TBL] [Abstract][Full Text] [Related]
13. Tumefactive demyelinating lesions.
Dagher AP; Smirniotopoulos J
Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
[TBL] [Abstract][Full Text] [Related]
14. A Review of Clinical and Imaging Findings in Tumefactive Demyelination.
Nakayama M; Naganawa S; Ouyang M; Jones KA; Kim J; Capizzano AA; Moritani T
AJR Am J Roentgenol; 2021 Jul; 217(1):186-197. PubMed ID: 34010036
[No Abstract] [Full Text] [Related]
15. [Tumefactive demyelinating lesion (TDL)].
Nakajima A; Kawachi I
No Shinkei Geka; 2021 Mar; 49(2):376-382. PubMed ID: 33762460
[TBL] [Abstract][Full Text] [Related]
16. Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.
Sun C; Han J; Lin Y; Qi X; Li C; Liu J; Qiu F
Front Immunol; 2022; 13():986473. PubMed ID: 36059526
[TBL] [Abstract][Full Text] [Related]
17. Tumefactive multiple sclerosis versus high-grade glioma: A diagnostic dilemma.
French HD
Surg Neurol Int; 2021; 12():199. PubMed ID: 34084626
[TBL] [Abstract][Full Text] [Related]
18. Differential imaging of atypical demyelinating lesions of the central nervous system.
Paoletti M; Muzic SI; Marchetti F; Farina LM; Bastianello S; Pichiecchio A
Radiol Med; 2021 Jun; 126(6):827-842. PubMed ID: 33486703
[TBL] [Abstract][Full Text] [Related]
19. The value of convolutional neural networks-based deep learning model in differential diagnosis of space-occupying brain diseases.
Miao X; Shao T; Wang Y; Wang Q; Han J; Li X; Li Y; Sun C; Wen J; Liu J
Front Neurol; 2023; 14():1107957. PubMed ID: 36816568
[TBL] [Abstract][Full Text] [Related]
20. Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma.
Bajagain M; Oyoshi T; Hanada T; Higa N; Hiraki T; Kamimura K; Kuroki S; Yoshimoto K
Surg Neurol Int; 2020; 11():342. PubMed ID: 33194276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
